O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Influenza Vaccines/therapeutic use,
Chloroquine/therapeutic use,
Hydroxychloroquine/therapeutic use,
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use,
Resveratrol/therapeutic use,
Copper/therapeutic use,
Interferon alpha-2/therapeutic use,
Midazolam/therapeutic use,
Ketamine/therapeutic use,
Fentanyl/therapeutic use,
Propofol/therapeutic use,
Immunoglobulins/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Methylprednisolone/therapeutic use,
Azithromycin/therapeutic use,
Enoxaparin/therapeutic use,
Cohort Studies,
Cross-Sectional Studies,
Technology Assessment, Biomedical
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
BCG Vaccine/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Enoxaparin/therapeutic use,
Fondaparinux/therapeutic use,
Hydroxychloroquine/therapeutic use,
Darunavir/therapeutic use,
Azithromycin/therapeutic use,
Heparin/therapeutic use,
Almitrine/therapeutic use,
Steroids/therapeutic use,
Histamine Antagonists/therapeutic use,
Nivolumab/therapeutic use,
Ipilimumab/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
Anticoagulants/therapeutic use,
Cohort Studies,
Technology Assessment, Biomedical
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Chloroquine/therapeutic use,
Hydroxychloroquine/therapeutic use,
Oseltamivir/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Heparin/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Azithromycin/therapeutic use,
Ascorbic Acid/therapeutic use,
Atorvastatin/therapeutic use,
Memantine/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Calcium Channel Blockers/therapeutic use,
Enoxaparin/therapeutic use,
Meropenem/therapeutic use,
Vancomycin/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Interleukin-6/antagonists & inhibitors,
Cohort Studies,
Cross-Sectional Studies/instrumentation,
Technology Assessment, Biomedical
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Pantoprazole/therapeutic use,
Esomeprazole/therapeutic use,
Omeprazole/therapeutic use,
Peptidyl-Dipeptidase A/therapeutic use,
Renin-Angiotensin System,
Hydroxychloroquine/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Extracorporeal Membrane Oxygenation/instrumentation,
Darunavir/therapeutic use,
Enoxaparin/therapeutic use,
Dexamethasone/therapeutic use,
Rituximab/therapeutic use,
Anticoagulants/therapeutic use,
Fibrinolytic Agents/therapeutic use,
Interleukin 1 Receptor Antagonist Protein/therapeutic use,
Cohort Effect,
Technology Assessment, Biomedical
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Ivermectin/therapeutic use,
Immunoglobulins/therapeutic use,
Interferon Type I/therapeutic use,
BCG Vaccine/therapeutic use,
Enoxaparin/therapeutic use,
Hydroxychloroquine/therapeutic use,
Azithromycin/therapeutic use,
Iloprost/therapeutic use,
Angiotensins/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Heparin/therapeutic use,
Vitamin D/therapeutic use,
Interleukin 1 Receptor Antagonist Protein/therapeutic use,
Cohort Studies,
Cross-Sectional Studies/instrumentation,
Technology Assessment, Biomedical
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Immunoglobulins/therapeutic use,
Antirheumatic Agents/therapeutic use,
Prednisone/therapeutic use,
Hydroxychloroquine/therapeutic use,
Enoxaparin/therapeutic use,
Fondaparinux/therapeutic use,
Anticoagulants/therapeutic use,
Azithromycin/therapeutic use,
Antiviral Agents/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Ivermectin/therapeutic use,
Cohort Studies,
Technology Assessment, Biomedical
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referente ao di...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Ribavirin/therapeutic use,
Chloroquine/therapeutic use,
Hydroxychloroquine/therapeutic use,
Interferons/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Azithromycin/therapeutic use,
Vasopeptidase Inhibitors/therapeutic use,
Angiotensin II Type 1 Receptor Blockers/therapeutic use,
Thalidomide/therapeutic use,
Methylprednisolone/therapeutic use,
Ceftriaxone/therapeutic use,
Ascorbic Acid/therapeutic use,
Enoxaparin/therapeutic use,
Technology Assessment, Biomedical
